Overview
Clinical Meaning
The neurochemistry of alcohol withdrawal involves dual neurotransmitter derangement.
PMHNP
PMHNP
The neurochemistry of alcohol withdrawal involves dual neurotransmitter derangement. Chronic ethanol potentiates GABA-A receptor chloride conductance while inhibiting NMDA receptor calcium influx. Compensatory neuroadaptation reduces GABA-A receptor expression (particularly alpha-1 subunit) and upregulates NMDA receptor density (NR2B subunit) and voltage-gated calcium channels. Abrupt cessation unmasks massive excitatory drive with glutamate-mediated excitotoxicity causing neuronal death and seizures. The kindling hypothesis explains progressive worsening: each withdrawal episode sensitizes neurons to subsequent withdrawal through long-term potentiation-like mechanisms. The clinician must prescribe evidence-based pharmacological protocols, manage complex medical comorbidities, order and interpret diagnostic studies, and coordinate long-term alcohol use disorder treatment including medication-assisted treatment (MAT).
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this PMHNP pathway. You can still explore topic-filtered questions from the bank hubs below.